Regeneron Pharmaceuticals' Assets Average rose 734.93% to $40.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $40.4 billion, marking a year-over-year increase of 734.93%. This contributed to the annual value of $39.2 billion for FY2025, which is 1055.69% up from last year.
Latest data reveals that Regeneron Pharmaceuticals reported Assets Average of $40.4 billion as of Q4 2025, which was up 734.93% from $39.2 billion recorded in Q3 2025.
Regeneron Pharmaceuticals' 5-year Assets Average high stood at $40.4 billion for Q4 2025, and its period low was $17.5 billion during Q1 2021.
In the last 5 years, Regeneron Pharmaceuticals' Assets Average had a median value of $30.9 billion in 2023 and averaged $30.8 billion.
Per our database at Business Quant, Regeneron Pharmaceuticals' Assets Average surged by 4822.6% in 2022 and then skyrocketed by 660.95% in 2025.
Over the past 5 years, Regeneron Pharmaceuticals' Assets Average (Quarter) stood at $24.6 billion in 2021, then increased by 15.86% to $28.4 billion in 2022, then increased by 14.68% to $32.6 billion in 2023, then increased by 15.26% to $37.6 billion in 2024, then rose by 7.35% to $40.4 billion in 2025.
Its Assets Average was $40.4 billion in Q4 2025, compared to $39.2 billion in Q3 2025 and $37.9 billion in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value